SYDNEY, January 22, 2019 – George Clinical, headquartered in Sydney, Australia, a global scientifically backed CRO, today announced the appointment of James Cheong to the role of Chief Operating Officer. With extensive management experience spanning over two decades, Cheong brings valuable leadership to George Clinical’s executive team during a period of strong expansion and growth. As COO, Cheong will lead global operations and direct the company’s administrative functions. Cheong will be based in the organization’s Singapore office.
“James joins George Clinical with a wealth of operational and commercial experience. His knowledge in clinical research, both as a sponsor as well as on the contract research side gives him unique insights for our staff and customers to leverage. These insights will help us continue to build on our strong Asian operational base and continue to grow our business globally. We are excited to have his experience at the helm as we continue to expand our customer base, services and geographic presence,” said Glenn Kerkhof, Chairman & Chief Executive Officer, George Clinical.
Prior to George Clinical, Cheong served as Head, Clinical Operations for the Chinese Market for Boehringer Ingelheim. During his tenure at Boehringer Ingelheim, he was responsible for clinical operations in China, Taiwan and Hong Kong covering trial monitoring and management, vendor, knowledge and quality management and medical writing.
Prior to Boehringer Ingelheim, Cheong acted as VP of Clinical Development at EPS International in Asia Pacific and has held various Asian leadership roles for major global CROs.
“Over the years, George Clinical has established itself as a leading CRO in Asia Pacific that delivers global operational excellence for our customers that is coupled with world-class scientific leadership. I am very excited to join the talented team at George Clinical during this period of expansion as we continue to grow from strength to strength in leveraging our unique value proposition to improve the health of millions of people worldwide,” said James Cheong, Chief Operating Officer, George Clinical.
About George Clinical
George Clinical is a leading independent Asia-Pacific and US-based clinical research organization (CRO) with global capabilities differentiated by scientific leadership, innovation and extensive investigator networks. With staff operating in 15 countries, and with significant operations in the USA, China, India and the broader Asia Pacific region, George Clinical provides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration and post-marketing trials.